Immunogenomic correlates of response to combination immune checkpoint blockade in advanced sarcoma.

被引:0
|
作者
Mitra, Akash [1 ]
Somaiah, Neeta [1 ]
Conley, Anthony P. [1 ]
Amini, Behrang [1 ]
Lin, Heather [1 ]
Sanchez, Beatriz E. [1 ]
Garcia-Prieto, Celia [1 ]
Mathew, Grace [1 ]
Bernatchez, Chantale [1 ]
Ravi, Vinod [1 ]
Araujo, Dejka [1 ]
Zarzour, Maria A. [1 ]
Livingston, John A. [1 ]
Roland, Christina L. [1 ]
Daw, Najat [1 ]
Baguley, Joshua [1 ]
Wang, Wei-Lien [1 ]
Beird, Hannah [1 ]
Tate, Taylor [1 ]
Haymaker, Cara [1 ]
Little, Latasha D. [1 ]
Gumbs, Curtis [1 ]
Song, Xingshi [1 ]
Keung, Emily Z. [1 ]
Zhang, Shaojun [1 ]
Gite, Swati [1 ]
Zhang, Jianhua [1 ]
Solis, Luisa [1 ]
Tawbi, Hussein [1 ]
Wang, Linghua [1 ]
Patel, Shreyaskumar [1 ]
Benjamin, Robert S. [1 ]
Lazar, Alexander J. [1 ]
Wistuba, Ignacio I. [1 ]
Futreal, Andrew [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
518
引用
收藏
页数:2
相关论文
共 50 条
  • [2] Genomic correlates of response to immune checkpoint blockade
    Keenan, Tanya E.
    Burke, Kelly P.
    Van Allen, Eliezer M.
    NATURE MEDICINE, 2019, 25 (03) : 389 - 402
  • [3] Genomic correlates of response to immune checkpoint blockade
    Tanya E. Keenan
    Kelly P. Burke
    Eliezer M. Van Allen
    Nature Medicine, 2019, 25 : 389 - 402
  • [4] Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
    Scott, Susan C.
    Shao, Xiaoshan M.
    Niknafs, Noushin
    Balan, Archana
    Pereira, Gavin
    Marrone, Kristen A.
    Lam, Vincent K.
    Murray, Joseph C.
    Feliciano, Josephine L.
    Levy, Benjamin P.
    Ettinger, David S.
    Hann, Christine L.
    Brahmer, Julie R.
    Forde, Patrick M.
    Karchin, Rachel
    Naidoo, Jarushka
    Anagnostou, Valsamo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Genomic correlates of response and resistance to immune checkpoint blockade
    Van Allen, Eliezer M.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [6] Immunogenomic features of pathologic response to neoadjuvant immune checkpoint blockade in esophageal cancer.
    Belcaid, Zineb
    Balan, Archana
    Cherry, Christopher
    Lanis, Mara
    Marrone, Kristen
    Levy, Benjamin Philip
    Schneider, Heather
    Rodavia, Hanika
    Jobe, Blair A.
    Thompson, Elizabeth
    Velculescu, Victor E.
    Battafarano, Richard James
    Yang, Stephen
    Broderick, Stephen
    Ha, Jinny Suk
    Zaidi, Ali H.
    Kelly, Ronan Joseph
    Feliciano, Josephine Louella
    Anagnostou, Valsamo
    Lam, Vincent K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB).
    Vokes, Natalie
    Margolis, Claire
    Liu, David
    Schilling, Bastian
    Schadendorf, Dirk
    Van Allen, Eliezer Mendel
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Response to Checkpoint Inhibitor Therapy in Advanced Classic Kaposi Sarcoma: A Case Report and Immunogenomic Study
    Saller, James
    Walko, Christine M.
    Millis, Sherri Z.
    Henderson-Jackson, Evita
    Makanji, Rikesh
    Brohl, Andrew S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (07): : 797 - 800
  • [9] A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
    Yang, Jing
    Zhao, Shilin
    Wang, Jing
    Sheng, Quanhu
    Liu, Qi
    Shyr, Yu
    CANCER RESEARCH, 2022, 82 (04) : 539 - 542
  • [10] Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma
    Spain, Lavinia
    Larkin, James
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 389 - 396